Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | PPM1B | O75688 | 3/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.38 |
| ▸ | PPP1CC | P36873 | 3/20 | 0.38 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL264307 | 0.90 | LMNA (0.44) | LMNATSHRALDH1A1KMT2AMAPT | |
| SCHEMBL572437 | 0.90 | LMNA (0.44) | LMNATSHRALDH1A1KMT2AMAPT | |
| SCHEMBL16909909 | 0.86 | POLB (0.48) | LMNAPOLBKDM4EAPEX1TDP1 | |
| SCHEMBL12226905 | 0.86 | POLB (0.48) | LMNAPOLBKDM4EAPEX1TDP1 | |
| SCHEMBL4968055 | 0.86 | POLB (0.48) | LMNAPOLBKDM4EAPEX1TDP1 | |
| SCHEMBL1664043 | 0.86 | POLB (0.48) | LMNAPOLBKDM4EAPEX1TDP1 | |
| SCHEMBL23064871 | 0.81 | LMNA (0.39) | LMNATSHRGRM1ALDH1A1KMT2A | |
| SCHEMBL392329 | 0.80 | PPM1B (0.59) | POLBTP53PPM1BPTPN1PPP1CC | |
| SCHEMBL4387586 | 0.80 | PPM1B (0.59) | POLBTP53PPM1BPTPN1PPP1CC | |
| SCHEMBL392595 | 0.80 | PPM1B (0.59) | POLBTP53PPM1BPTPN1PPP1CC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2307476-A1 | ASYMMETRIC CYCLIC DIESTER COMPOUNDS | FERRO CORPORATION (US) | 2011-04-13 | — | — | EP | claimed |
| WO-2009152068-A1 | ASYMMETRIC CYCLIC DIESTER COMPOUNDS | FERRO CORPORATION (US) | 2009-12-17 | — | — | WO | claimed |
| US-20090312470-A1 | Asymmetric Cyclic Diester Compounds | FERRO CORPORATION (US) | 2009-12-17 | — | — | US | claimed |
| JP-2038415-A | — | — | None | — | — | JP | disclosed |
| JP-3277622-A | — | — | None | — | — | JP | disclosed |
| EP-3723160-B1 | SEPARATOR FOR LITHIUM-SULFUR BATTERY AND LITHIUM-SULFUR BATTERY INCLUDING SAME | LG ENERGY SOLUTION LTD (KR) | 2025-03-26 | — | — | EP | disclosed |
| EP-3712984-B1 | SEPARATOR FOR LITHIUM-SULFUR BATTERY AND LITHIUM-SULFUR BATTERY COMPRISING SAME | LG ENERGY SOLUTION LTD (KR) | 2024-11-06 | — | — | EP | disclosed |
| US-11999872-B2 | Separator for lithium-sulfur battery and lithium-sulfur battery including same | LG ENERGY SOLUTION, LTD. (KR) | 2024-06-04 | — | — | US | disclosed |
| EP-3440051-B1 | NEUROPEPTIDE S RECEPTOR (NPSR) AGONISTS | RES TRIANGLE INST (US) | 2024-03-20 | — | — | EP | disclosed |
| WO-2023056263-A1 | CADAVERINE-BASED POLYIMIDES | ZYMERGEN INC. (US) | 2023-04-06 | — | — | WO | disclosed |
| US-11581614-B2 | Separator including coating layer with polymer having main chain with non-covalent electron pair and aromatic side chain and lithium-sulfur battery having the same | LG ENERGY SOLUTION, LTD. (KR) | 2023-02-14 | — | — | US | disclosed |
| US-4937249-A | Neuroleptic agents | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1990-06-26 | — | — | US | disclosed |
| JP-H0238415-A | CURING AGENT FOR EPOXY RESIN | TONEN CORP | 1990-02-07 | — | — | JP | disclosed |
| EP-0314098-A2 | Imide derivatives, their production and use | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1989-05-03 | — | — | EP | disclosed |
| US-4824884-A | Cyclic anhydride derivatives of hydrazide functionalized hindered amine light stabilizers | PENNWALT CORPORATION (US) | 1989-04-25 | — | — | US | disclosed |
| US-4812461-A | Imide derivatives and their use in the treatment psychosis | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1989-03-14 | — | — | US | disclosed |
| EP-0303282-A2 | Cyclic anhydride derivatives of hydrazide functionalized hindered amine light stabilizers | ATOCHEM NORTH AMERICA, INC. (US) | 1989-02-15 | — | — | EP | disclosed |
| EP-0261688-A1 | Imide derivatives, and their production and use | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1988-03-30 | — | — | EP | disclosed |
| US-4543355-A | Substituted succinimides, compositions and method of use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-09-24 | — | — | US | disclosed |
| US-4507303-A | Succinimide derivatives, compositions and method of use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090312470-A1 | Asymmetric Cyclic Diester Compounds | DDT, PCNA, AADAC | LMNA 3399/4885POLB 582/4885KDM4E 1680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.